Cargando…

Profiling the dynamic expression of checkpoint molecules on cytokine-induced killer cells from non-small-cell lung cancer patients

Immune checkpoints associate with dysfunctional T cells, which have a reduced ability to clear pathogens or cancer cells. T-cell checkpoint blockade may improve patient survival. However, checkpoint molecules on cytokine-induced killer (CIK) cell, a non-specific adoptive immunotherapy, remain unknow...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Lin, Wang, Jian, Wei, Feng, Wang, Kaiyuan, Sun, Qian, Yang, Fan, Jin, Hao, Zheng, Yu, Zhao, Hua, Wang, Limei, Yu, Wenwen, Zhang, Xiying, An, Yang, Yang, Lili, Zhang, Xinwei, Ren, Xiubao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5190047/ https://www.ncbi.nlm.nih.gov/pubmed/27283895 http://dx.doi.org/10.18632/oncotarget.9871

Ejemplares similares

The prognostic landscape of genes and infiltrating immune cells in cytokine induced killer cell treated-lung squamous cell carcinoma and adenocarcinoma
por: Wang, Jian, et al.
Publicado: (2021)

Herceptin Enhances the Antitumor Effect of Natural Killer Cells on Breast Cancer Cells Expressing Human Epidermal Growth Factor Receptor-2
por: Tian, Xiao, et al.
Publicado: (2017)

Cytokine-Induced Killer Cells Modulates Resistance to Cisplatin in the A549/DDP Cell Line
por: Yang, Lili, et al.
Publicado: (2017)

Efficiency of Cytokine-Induced Killer Cells in Combination with Chemotherapy for Triple-Negative Breast Cancer
por: Li, Man, et al.
Publicado: (2018)

Rapid Response of Advanced Squamous Non-Small Cell Lung Cancer with Thrombocytopenia after First-Line Treatment with Pembrolizumab Plus Autologous Cytokine-Induced Killer Cells
por: Hui, Zhenzhen, et al.
Publicado: (2015)

Randomized, multicenter, open-label trial of autologous cytokine-induced killer cell immunotherapy plus chemotherapy for squamous non-small-cell lung cancer: NCT01631357
por: Liu, Liang, et al.
Publicado: (2020)

Morphine-3-glucuronide upregulates PD-L1 expression via TLR4 and promotes the immune escape of non-small cell lung cancer
por: Wang, Kaiyuan, et al.
Publicado: (2021)

Autologous cytokine‐induced killer (CIK) cells enhance the clinical response to PD‐1 blocking antibodies in patients with advanced non‐small cell lung cancer: A preliminary study
por: Han, Ying, et al.
Publicado: (2020)

T-cell receptor gene therapy targeting melanoma-associated antigen-A4 by silencing of endogenous TCR inhibits tumor growth in mice and human
por: Sun, Qian, et al.
Publicado: (2019)

Effect of Chemotherapeutics on In Vitro Immune Checkpoint Expression in Non-Small Cell Lung Cancer
por: Zhao, Yu, et al.
Publicado: (2023)

Soluble Toll-like receptor 4 is a potential serum biomarker in non-small cell lung cancer
por: Wei, Feng, et al.
Publicado: (2016)

EZH2 identifies the precursors of human natural killer cells with trained immunity
por: Zhang, Chen, et al.
Publicado: (2021)

Nociceptin Receptor Is Overexpressed in Non-small Cell Lung Cancer and Predicts Poor Prognosis
por: Wang, Kaiyuan, et al.
Publicado: (2019)

Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy
por: Cao, Yuqing, et al.
Publicado: (2020)

A dynamic transcriptomic atlas of cytokine-induced killer cells
por: Meng, Mingyao, et al.
Publicado: (2018)

Expression of TLR4 in Non-Small Cell Lung Cancer Is Associated with PD-L1 and Poor Prognosis in Patients Receiving Pulmonectomy
por: Wang, Kaiyuan, et al.
Publicado: (2017)

Somatic copy number alteration predicts clinical benefit of lung adenocarcinoma patients treated with cytokine-induced killer plus chemotherapy
por: Kou, Fan, et al.
Publicado: (2022)

Cytokine-induced killer cell/dendritic cell combined with cytokine-induced killer cell immunotherapy for treating advanced gastrointestinal cancer
por: Du, Hansong, et al.
Publicado: (2020)

Single-Cell Sequencing Reveals the Transcriptome and TCR Characteristics of pTregs and in vitro Expanded iTregs
por: Hui, Zhenzhen, et al.
Publicado: (2021)

Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer in China: a meta-analysis
por: Liu, Yan, et al.
Publicado: (2017)

Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer: A meta-analysis
por: Yuan, Xin, et al.
Publicado: (2021)

CD4(+) T cells are required to improve the efficacy of CIK therapy in non-small cell lung cancer
por: Liu, Shaochuan, et al.
Publicado: (2022)

Trained Immunity of IL-12-, IL-15-, and IL-18-Induced CD(3)+CD(56)+ NKT-Like Cells
por: Zhu, Siyu, et al.
Publicado: (2022)

Potential value of efficacy prediction and treatment of natural killer cells in extensive stage small cell lung cancer
por: Cui, Yanan, et al.
Publicado: (2023)

Pathologic complete response to immune checkpoint inhibitor in a stage IIIB ovarian clear cell carcinoma patient with POLE mutation resistant to platinum-based chemotherapy: a case report
por: Li, Shuzhan, et al.
Publicado: (2022)

Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells
por: Kim, Nayoung, et al.
Publicado: (2018)

Interleukin-6 Trans-Signaling Pathway Promotes Immunosuppressive Myeloid-Derived Suppressor Cells via Suppression of Suppressor of Cytokine Signaling 3 in Breast Cancer
por: Jiang, Mengmeng, et al.
Publicado: (2017)

Significantly different immunological score in lung adenocarcinoma and squamous cell carcinoma and a proposal for a new immune staging system
por: Zeng, Ziqing, et al.
Publicado: (2020)

Downregulation of PD‐L1 and HLA‐I in non‐small cell lung cancer with ALK fusion
por: Mu, Di, et al.
Publicado: (2022)

Upregulated expression of indoleamine 2, 3-dioxygenase in CHO cells induces apoptosis of competent T cells and increases proportion of Treg cells
por: Sun, Jingyan, et al.
Publicado: (2011)

A small-molecule/cytokine combination enhances hematopoietic stem cell proliferation via inhibition of cell differentiation
por: Wang, Lan, et al.
Publicado: (2017)

Correction to: A small-molecule/cytokine combination enhances hematopoietic stem cell proliferation via inhibition of cell differentiation
por: Wang, Lan, et al.
Publicado: (2021)

Adoptive Immunotherapy of Cytokine-Induced Killer Cell Therapy in the Treatment of Non-Small Cell Lung Cancer
por: Wang, Min, et al.
Publicado: (2014)

Memory stem T cells generated by Wnt signaling from blood of human renal clear cell carcinoma patients
por: Yan, Cihui, et al.
Publicado: (2019)

Efficacy of cytokine-induced killer cell infusion as an adjuvant immunotherapy for hepatocellular carcinoma: a systematic review and meta-analysis
por: Yu, Ruili, et al.
Publicado: (2017)

Sintilimab maintenance therapy post first-line cytokine-induced killer cells plus chemotherapy for extensive-stage small cell lung cancer
por: Ma, Baozhen, et al.
Publicado: (2022)

Cytokine-induced killer cell/dendritic cell–cytokine-induced killer cell immunotherapy for the postoperative treatment of gastric cancer: A systematic review and meta-analysis
por: Wang, Xiang, et al.
Publicado: (2018)

Cytokine-induced killer cells/dendritic cells-cytokine induced killer cells immunotherapy combined with chemotherapy for treatment of colorectal cancer in China: a meta-analysis of 29 trials involving 2,610 patients
por: Zhang, Lei, et al.
Publicado: (2017)

Cytokine-induced killer cells: A novel immunotherapy strategy for leukemia
por: YANG, XIN-YU, et al.
Publicado: (2015)

Factors related to rapid progression of non‐small cell lung cancer in Chinese patients treated using single‐agent immune checkpoint inhibitor treatment
por: Zhang, Liang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6offns4em1ssraeu1fi87p1cta